2025 HCPCS Code C1739
Tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system
TAGS: system identifiable detectable method uniquely delivery tissue| Short Description | Marker uniq detect w/prbe |
| HCPCS Action Code | C - Change in long description of procedure or modifier code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | January 01, 2025 |
| HCPCS Action Effective Date | October 01, 2025 |
| HCPCS Pricing Indicator Code | 53 - Statute |
| HCPCS Type Of Service Code | 9 - Other medical items or services |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9464 - Injection, rolapitant
- C9465 - Injection, durolane
- C9466 - Injection, benralizumab
- C9467 - Inj rituximab hyaluronidase
- C9468 - Inj, factor ix, rebinyn
- C9469 - Inj triamcinolone acetonide
- C9470 - Aripiprazole lauroxil im
- C9471 - Hymovis, 1 mg
- C9472 - Inj talimogene laherparepvec
- C9473 - Injection, mepolizumab
- C9474 - Inj, irinotecan liposome
- C9475 - Injection, necitumumab
- C9476 - Injection, daratumumab
- C9477 - Injection, elotuzumab
- C9478 - Injection, sebelipase alfa
- C9479 - Instill, ciprofloxacin otic
- C9480 - Injection, trabectedin
- C9481 - Injection, reslizumab
- C9482 - Sotalol hydrochloride iv
- C9483 - Injection, atezolizumab